1. Home
  2. EVO vs SYRE Comparison

EVO vs SYRE Comparison

Compare EVO & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVO
  • SYRE
  • Stock Information
  • Founded
  • EVO 1993
  • SYRE 2013
  • Country
  • EVO Germany
  • SYRE United States
  • Employees
  • EVO N/A
  • SYRE N/A
  • Industry
  • EVO Biotechnology: Pharmaceutical Preparations
  • SYRE Biotechnology: Pharmaceutical Preparations
  • Sector
  • EVO Health Care
  • SYRE Health Care
  • Exchange
  • EVO Nasdaq
  • SYRE Nasdaq
  • Market Cap
  • EVO 1.2B
  • SYRE 1.1B
  • IPO Year
  • EVO 2021
  • SYRE 2016
  • Fundamental
  • Price
  • EVO $3.93
  • SYRE $21.15
  • Analyst Decision
  • EVO Strong Buy
  • SYRE Strong Buy
  • Analyst Count
  • EVO 1
  • SYRE 6
  • Target Price
  • EVO $7.00
  • SYRE $57.60
  • AVG Volume (30 Days)
  • EVO 44.7K
  • SYRE 711.6K
  • Earning Date
  • EVO 11-05-2025
  • SYRE 11-06-2025
  • Dividend Yield
  • EVO N/A
  • SYRE N/A
  • EPS Growth
  • EVO N/A
  • SYRE N/A
  • EPS
  • EVO N/A
  • SYRE N/A
  • Revenue
  • EVO $912,894,891.00
  • SYRE N/A
  • Revenue This Year
  • EVO N/A
  • SYRE N/A
  • Revenue Next Year
  • EVO $10.78
  • SYRE N/A
  • P/E Ratio
  • EVO N/A
  • SYRE N/A
  • Revenue Growth
  • EVO N/A
  • SYRE N/A
  • 52 Week Low
  • EVO $2.84
  • SYRE $10.91
  • 52 Week High
  • EVO $5.64
  • SYRE $40.26
  • Technical
  • Relative Strength Index (RSI)
  • EVO 59.84
  • SYRE 72.55
  • Support Level
  • EVO $3.93
  • SYRE $16.04
  • Resistance Level
  • EVO $4.02
  • SYRE $17.18
  • Average True Range (ATR)
  • EVO 0.08
  • SYRE 1.15
  • MACD
  • EVO 0.04
  • SYRE 0.40
  • Stochastic Oscillator
  • EVO 78.26
  • SYRE 98.20

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: